Abstract
An efficient and practical asymmetric synthesis of 1- tert-butyl 3-methyl (3 R,4 R)-4-(2-oxo-2,3-dihydro-1 H-benzimidazol-1-yl)piperidine-1,3-dicarboxylate 1, a useful intermediate for the synthesis of nociceptin antagonists, has been developed. This method includes the following key steps: (1) diastereoselective reduction of a chiral enaminoester 3 having ( R)-1-phenylethylamine as a chiral pool constituent with the use of a combined TFA–NaBH 4 reduction system and (2) efficient isomerization from 3,4- cis-substituted piperidine 8 to 3,4- trans-substituted piperidine 1 under basic conditions. The above methods proved to be applicable for large-scale operation and hundred grams of enantiomerically pure compound 1 (>98% ee) was obtained.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.